Effectiveness, pharmacokinetics, and safety of triptorelin acetate microspheres in patients with locally advanced and metastatic prostate cancer.

Journal: Therapeutic advances in medical oncology
Published Date:

Abstract

BACKGROUND: A newly generic microspheres, sustained-release formulation of triptorelin acetate 3.75 mg has been developed.

Authors

  • Guolan Wu
    Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Feng Zhou
    Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Haiping Wang
    Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Kan Liu
    Department of Urology, Hunan Cancer Hospital, Changsha, Hunan, China.
  • Dexin Yu
    Department of Urology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Lianlian Fan
    Phase 1 Clinical Trial Center, Deyang People's Hospital, Deyang, Sichuan, China.
  • Yangyun Han
    Deyang People's Hospital, Deyang, Sichuan, China.
  • Xiaohong Ai
    Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Youhan Cao
    Department of Urology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Xiaolin Wang
    Department of Urology, Nantong Tumor Hospital, Nantong, Jiangsu, China.
  • Sheng Wang
    Intensive Care Medical Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, People's Republic of China.
  • Chaohong He
    Department of Urology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Jitao Wu
    Department of Urology, Yantai Yuhuangding Hospital, Yantai, Shandong, China.
  • Ji Wu
    Department of Urology, Nanchong Central Hospital, Nanchong, Sichuan, China.
  • Youlei Wang
    Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Yanqing Wang
    Clinical Research Management Center, Livzon Pharmaceutical Group Inc., Zhuhai, Guangdong, China.
  • Baiye Jin
    Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Jianzhong Shentu
    Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, Zhejiang 310003, China.

Keywords

No keywords available for this article.